Imaging endometriosis with a special PET tracer in adult women
Official title: Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis
Run by Universitaire Ziekenhuizen KU Leuven · NCT07876648 · Data updated 2026-11-12
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | Women only |
| Enrollment | 64 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Leuven) |
| Status | Recruiting |
| Started | September 30, 2026 |
| Main results expected | August 31, 2029 |
| Study ends | August 31, 2029 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07876648 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women (18+) with suspected deep infiltrating or superficial peritoneal endometriosis who are scheduled for laparoscopy.
✕Probably not a fit
Patients whose lesions are not detected by PET/CT or who do not have lesions adjacent to surgical targets may not see a direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective imaging study evaluates the use of [18F]AlF-FAPI-74 PET/CT to detect endometriosis before laparoscopic surgery in adult women. Participants receive the tracer, then undergo PET/CT followed by planned laparoscopy, with surgical findings and tissue analysis used for comparison. An optional NeuroEXPLORER high-resolution PET/CT may be performed after the same tracer dose to see if smaller lesions can be identified. The study aims to determine how well the tracer identifies lesions seen during surgery and whether it reveals additional lesions beyond ultrasound or MRI.
Why it matters
Potential benefit: If successful, this imaging approach could improve preoperative detection of endometriosis and help guide surgical planning.
How similar studies have gone: Prior research in oncology and other diseases supports FAPI-based PET imaging; this exact endometriosis application is exploratory and builds on emerging evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Voluntary written informed consent of the participant has been obtained prior to any screening procedures. * At least 18 years of age at the time of signing the Informed Consent Form (ICF). * At least one of the following to be eligible for the DE cohort: (i) Clinical suspicion of DE, defined as the presence of deep nodule(s) during vaginal examination determined by a clinician who is an expert in endometriosis. (ii) Diagnostic suspicion of DE, defined as an ultrasound and/or MRI that shows lesions suspicious for DE. * At least one of the following to be eligible for the SPE cohort: (i) Clinical suspicion of SPE, defined as clinical symptoms suspicious of SPE determined by a clinician who is an expert in endometriosis. These clinical symptoms include dysmenorrhea, deep dyspareunia, dysuria, dyschezia, painful rectal bleeding or haematuria, shoulder tip pain, catamenial pneumothorax, cyclical cough/haemoptysis/chest pain, cyclical scar swelling and pain, fatigue, and infertility. (ii) Diagnostic suspicion of SPE, defined as an ultrasound and/or MRI that shows lesions suspicious for SPE. * Planned laparoscopy for suspected endometriosis. Exclusion Criteria: * For SPE cohort: (i) Ultrasound and/or MRI with lesions suspicious of ovarian endometriosis and/or DE. (ii) Clinical symptoms suspicious of ovarian endometriosis and/or DE, determined by a clinician who is an expert in endometriosis. * Prior abdominal surgery less than one year ago. * Female who is pregnant, breastfeeding or is of childbearing potential and not using an adequate, highly effective contraceptive or no usage of contraception when sexually active are not accepted. * Participant is mentally or legally incapacitated, does not understand the study design or is not willing or capable to undergo all study-specific procedures. * Any disorder or condition, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol, or may influence the result of the study. * Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial. * Participation in an interventional Trial with an investigational medicinal product (IMP) or device when the trial designs are not considered compatible by the study team. * Participation in a clinical scientific study in the last 12 months with a radiation exposure caused by the experimental procedures greater than 1 mSv. * Participant has a known hypersensitivity to \[18F\]AlF-FAPI-74 or the used excipients.
Where it's running
-
UZ Leuven
Leuven, Belgium Recruiting
Study contacts
- Study coordinator: Niloefar Ahmadi Bidakhvidi
- Email: niloefar.ahmadibidakhvidi@uzleuven.be
- Phone: +3216343715
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.